(6 May, 2024) Guangzhou-Israel Biotechnology Fund (GIBF) announced today that it has invested $10 million in Nectin Therapeutics Ltd, proceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates.

(18 March, 2024) Nectin Therapeutics Ltd. (" Nectin "), the parent company of Guangzhou Nectin Pharma Ltd. has been selected as one of the 42 recipients of EIC funding in the 2023 EIC Accelerator from a competitive field of 1,083 proposals and 242 companies that were reviewed.

(25 Dec, 2023) Israeli Foreign Affairs Minister Mr. Eli Cohen awarded certificates of appreciation to businessmen and organizations for their contribution to Israel's foreign relations and strengthening its global position.

(16 Nov, 2023) Visionix USA is proud to share they recently entered a strategic alliance with 20/20NOW to help bring cost effective, in-office, quality synchronous tele-optometry comprehensive eye exams and ocular telemedicine closer to more patients throughout the United States.

(30 Oct, 2023) Results from a multinational Phase 2 clinical study (Protact Trial) of siRNA directed against the oncogenic KRAS G12D and G12V mutations  in an extended release formulation (Loder™) was presented at the 2023 European Society for Medical Oncology (ESMO) annual congress (Abstract 1626P). 

(8 Jun, 2023) CorNeat Vision's EverPatch utilizes EverMatrix™, a novel material technology able to integrate with surrounding tissue

(18 Sep, 2022) Kamari Pharma announced the completion of an $8 million investment by the Chinese fund GIBF2.

(11 Sep, 2021) Guangzhou Sino-Israel Biotech Investment Fund (GIBF) recently completed a $ 4 million investment in the Israeli subsidiary of Kornit Vision, which was established in Guangzhou, China.

(31 May 2021) The Guangzhou Sino-Israel Bio-industry Investment Fund, headed by Israel’s former chief scientist, has already closed $200 million for its second fund to finance clinical trials.